GeneCker Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $10.3M

  • Investors
  • 10

GeneCker General Information

Description

Developer of a CRISPR-based liquid biopsy diagnostic technology designed to standardize the detection of genetic mutations in clinical samples. The company offers ultra-precision wild-type DNA cleavage and mutant DNA amplification capabilities, enabling healthcare providers and individuals to identify disease-associated genetic mutations with greater accuracy.

Contact Information

Website
www.genecker.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1002-1004, 26 Seongsuil-ro
  • 10-gil Seongdong-gu
  • Seoul, 04793
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 1002-1004, 26 Seongsuil-ro
  • 10-gil Seongdong-gu
  • Seoul, 04793
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneCker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 04-Dec-2025 $10.3M Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC (Series B) 05-May-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Oct-2019 $1.67M $1.93M Completed Generating Revenue
1. Seed Round 01-Jun-2019 $254K $254K Completed Generating Revenue
To view GeneCker’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

GeneCker Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

GeneCker Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4463544-A1 Cas9 proteins with enhanced specificity and uses thereof Pending 12-Jan-2022
EP-4463544-A4 Cas9 proteins with enhanced specificity and uses thereof Pending 12-Jan-2022
US-20230332120-A1 Cas9 proteins with enhanced specificity and uses thereof Pending 12-Jan-2022
WO-2023135524-A1 Cas9 proteins with enhanced specificity and uses thereof Inactive 12-Jan-2022
ES-2962531-T3 Cell-free mutant dna isolation method and kit Active 06-Feb-2018 C12Q1/6858
To view GeneCker’s complete patent history, request access »

GeneCker Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GeneCker Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aju Pharmaceutical Holding Company Minority
A Ventures Venture Capital Minority
Devsisters Ventures Corporate Venture Capital Minority
Friend Investment Partners (Seoul) Venture Capital Minority
Magna Investment (Seoul) Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

GeneCker FAQs

  • When was GeneCker founded?

    GeneCker was founded in 2017.

  • Where is GeneCker headquartered?

    GeneCker is headquartered in Seoul, South Korea.

  • What is the size of GeneCker?

    GeneCker has 37 total employees.

  • What industry is GeneCker in?

    GeneCker’s primary industry is Diagnostic Equipment.

  • Is GeneCker a private or public company?

    GeneCker is a Private company.

  • What is GeneCker’s current revenue?

    The current revenue for GeneCker is .

  • How much funding has GeneCker raised over time?

    GeneCker has raised $18.6M.

  • Who are GeneCker’s investors?

    Aju Pharmaceutical, A Ventures, Devsisters Ventures, Friend Investment Partners (Seoul), and Magna Investment (Seoul) are 5 of 10 investors who have invested in GeneCker.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process